$LRHC - La Rosa Holdings Corp. Reports Unaudited Preliminary Revenue of Approximately $65 Million for Fiscal Year 2024, Achieving 104% Year-Over-Year Growth
$PSTV - Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium
$NHWK - NightHawks Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program